Taysha Gene Therapies: Q1 Earnings Insights

Taysha Gene Therapies TSHA reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Taysha Gene Therapies missed estimated earnings by 22.43%, reporting an EPS of $-1.31 versus an estimate of $-1.07.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.07 which was followed by a 2.76% drop in the share price the next day.

To track all earnings releases for Taysha Gene Therapies visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.